Contemporary treatment of coronary bifurcations with drug-eluting stent: part II.
作者信息
Colombo Antonio
机构信息
EMO Centro Cuore Columbus, San Raffaele Hospital, Milan, Italy.
出版信息
J Interv Cardiol. 2006 Feb;19(1):51-3. doi: 10.1111/j.1540-8183.2006.00104.x.
Abstract
摘要
相似文献
1
Contemporary treatment of coronary bifurcations with drug-eluting stent: part II.
J Interv Cardiol. 2006 Feb;19(1):51-3. doi: 10.1111/j.1540-8183.2006.00104.x.
2
Effectiveness of sirolimus-eluting stent implantation for the treatment of coronary artery disease in octogenarians.
Am J Cardiol. 2004 Oct 1;94(7):909-13. doi: 10.1016/j.amjcard.2004.06.036.
3
Platelet glycoprotein IIb/IIIa receptor inhibitors: is their future as bright as their past?
Catheter Cardiovasc Interv. 2008 Jun 1;71(7):907-8. doi: 10.1002/ccd.21622.
4
Paclitaxel- versus sirolimus-eluting stents for unprotected left main coronary artery disease.
J Am Coll Cardiol. 2009 May 12;53(19):1760-8. doi: 10.1016/j.jacc.2009.01.035.
5
Editorial comment: which is the preferred drug-eluting stent?
J Interv Cardiol. 2006 Feb;19(1):39-42. doi: 10.1111/j.1540-8183.2006.00102.x.
6
The paclitaxel-eluting stent in percutaneous coronary intervention: Part II. Comparison with the sirolimus-eluting stent, economics, and unanswered questions.
Cardiol Rev. 2006 May-Jun;14(3):143-50. doi: 10.1097/01.crd.0000214683.72810.87.
7
Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
Catheter Cardiovasc Interv. 2006 Nov;68(5):663-8. doi: 10.1002/ccd.20741.
8
XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
Expert Rev Med Devices. 2007 Jan;4(1):11-21. doi: 10.1586/17434440.4.1.11.
9
Status of drug-eluting coronary stents.
Med Health R I. 2008 Oct;91(10):309-12, 314.
10
[Percutaneous coronary intervention].
Orv Hetil. 2005 Mar 27;146(13):587-93.
Zotero 插件